ProfileGDS4718 / 201003_x_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 95% 94% 85% 96% 96% 89% 91% 95% 95% 95% 94% 95% 94% 91% 92% 96% 96% 93% 95% 92% 96% 96% 95% 94% 94% 93% 95% 89% 95% 91% 93% 93% 96% 95% 93% 93% 92% 96% 95% 81% 96% 90% 91% 93% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]10.391695
GSM549102patient 115, normal, homogenized [OPG study]9.9379394
GSM549104patient 119, normal, homogenized [OPG study]8.5160685
GSM549108patient 138, normal, homogenized [OPG study]10.509996
GSM549119patient 077, normal, homogenized [OPG study]10.503196
GSM549133patient 032, cancer, homogenized [OPG study]9.2062289
GSM549139patient 042, cancer, homogenized [OPG study]9.2909891
GSM549099patient 107, normal, homogenized [OPG study]10.118695
GSM549109patient 139, normal, homogenized [OPG study]10.233795
GSM549110patient 046, normal, homogenized [OPG study]10.337595
GSM549114patient 063, normal, homogenized [OPG study]10.186394
GSM549122patient 082, normal, homogenized [OPG study]10.176195
GSM549134patient 033, cancer, homogenized [OPG study]10.013794
GSM549136patient 036, cancer, homogenized [OPG study]9.3486891
GSM549140patient 044, cancer, homogenized [OPG study]9.6289192
GSM549111patient 047, normal, homogenized [OPG study]10.53996
GSM549113patient 057, normal, homogenized [OPG study]10.731996
GSM549132patient 031, cancer, homogenized [OPG study]9.7020793
GSM549137patient 038, cancer, homogenized [OPG study]10.0295
GSM549142patient 047, cancer, homogenized [OPG study]8.9833392
GSM549100patient 110, normal, homogenized [OPG study]10.674496
GSM549107patient 135, normal, homogenized [OPG study]10.530496
GSM549115patient 068, normal, homogenized [OPG study]10.513295
GSM549116patient 072, normal, homogenized [OPG study]10.223994
GSM549120patient 078, normal, homogenized [OPG study]9.9338594
GSM549131patient 030, cancer, homogenized [OPG study]9.793993
GSM549118patient 074, normal, homogenized [OPG study]10.213995
GSM549129patient 027, cancer, homogenized [OPG study]8.9441589
GSM549123patient 088, normal, homogenized [OPG study]10.402595
GSM549124patient 006, cancer, homogenized [OPG study]9.2960491
GSM549126patient 015, cancer, homogenized [OPG study]9.7431693
GSM549128patient 025, cancer, homogenized [OPG study]9.6835193
GSM549103patient 117, normal, homogenized [OPG study]10.657496
GSM549117patient 073, normal, homogenized [OPG study]10.403395
GSM549138patient 041, cancer, homogenized [OPG study]9.8362793
GSM549141patient 045, cancer, homogenized [OPG study]9.8227693
GSM549130patient 028, cancer, homogenized [OPG study]9.4272892
GSM549101patient 111, normal, homogenized [OPG study]10.441996
GSM549105patient 128, normal, homogenized [OPG study]10.166595
GSM549106patient 134, normal, homogenized [OPG study]8.1874681
GSM549112patient 048, normal, homogenized [OPG study]10.538796
GSM549125patient 011, cancer, homogenized [OPG study]9.151390
GSM549127patient 024, cancer, homogenized [OPG study]9.3148291
GSM549135patient 035, cancer, homogenized [OPG study]9.7897493